Last Updated: 08/04/2021

Development of a single administration, extended release (14 days) capsule to deliver ivermectin as a malaria endectocide

Objectives

The purpose of this grant is to develop a single administration, extended release (14 days) capsule to deliver ivermectin as a malaria endectocide.

Principal Institution

Lyndra Inc., United States

Date

Oct 2020 — Dec 2023

Total Project Funding

$3.1M

Funding Details
Gates Foundation (GF), United States

Grant number: INV016231
Project Site

United States

SHARE
SHARE